Reducing In-Stent Restenosis: Therapeutic Manipulation of miRNA in Vascular Remodeling and Inflammation.
Reducing In-Stent Restenosis: Therapeutic Manipulation of miRNA in Vascular Remodeling and Inflammation.
复制标题
DOI:
10.1016/j.jacc.2015.03.549
复制
发表时间:
2015-06-02
影响因子:
24
通讯作者:
Baker AH
中科院分区:
文献类型:
--
作者:
McDonald RA;Halliday CA;Miller AM;Diver LA;Dakin RS;Montgomery J;McBride MW;Kennedy S;McClure JD;Robertson KE;Douglas G;Channon KM;Oldroyd KG;Baker AH
Drug-eluting stents reduce the incidence of in-stent restenosis, but they result in delayed arterial healing and are associated with a chronic inflammatory response and hypersensitivity reactions. Identifying novel interventions to enhance wound healing and reduce the inflammatory response may improve long-term clinical outcomes. Micro–ribonucleic acids (miRNAs) are noncoding small ribonucleic acids that play a prominent role in the initiation and resolution of inflammation after vascular injury. This study sought to identify miRNA regulation and function after implantation of bare-metal and drug-eluting stents. Pig, mouse, and in vitro models were used to investigate the role of miRNA in in-stent restenosis. We documented a subset of inflammatory miRNAs activated after stenting in pigs, including the miR-21 stem loop miRNAs. Genetic ablation of the miR-21 stem loop attenuated neointimal formation in mice post-stenting. This occurred via enhanced levels of anti-inflammatory M2 macrophages coupled with an impaired sensitivity of smooth muscle cells to respond to vascular activation. MiR-21 plays a prominent role in promoting vascular inflammation and remodeling after stent injury. MiRNA-mediated modulation of the inflammatory response post-stenting may have therapeutic potential to accelerate wound healing and enhance the clinical efficacy of stenting.